• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌

Hepatocellular carcinoma.

作者信息

Akriviadis E A, Llovet J M, Efremidis S C, Shouval D, Canelo R, Ringe B, Meyers W C

机构信息

Radiology Department, Hippocration Hospital, Thessaloniki, Greece.

出版信息

Br J Surg. 1998 Oct;85(10):1319-31. doi: 10.1046/j.1365-2168.1998.00865.x.

DOI:10.1046/j.1365-2168.1998.00865.x
PMID:9782009
Abstract

BACKGROUND

Hepatocellular carcinoma is one of the world's most common malignancies. The aims of the present paper are to review data on (1) epidemiology and screening programmes for the early detection of the tumour and (2) advances in the diagnostic imaging and management.

METHODS

Relevant English language articles, published between January 1985 and December 1997, were reviewed. Articles were identified through Medline search, using the key words 'hepatocellular carcinoma'. Articles cited in the bibliographies of these articles were searched manually.

RESULTS

Hepatocellular carcinoma has a heterogeneous geographical distribution. Although its risk factors have been identified, the efficacy of screening programmes remains uncertain. Imaging has improved substantially with the recent application of dual-phase helical computed tomography and magnetic resonance imaging employing specific contrast agents. The comparative efficacy of conservative therapy and surgical resection is uncertain, since well controlled trials are lacking.

CONCLUSION

Hepatocellular carcinoma is commonly a problem of two diseases, the malignancy itself and cirrhosis. This renders treatment rarely curative, even when surgical resection can be applied in a technically successful sense. Liver transplantation could be a definitive treatment but this is plagued by limited donor resources.

摘要

背景

肝细胞癌是全球最常见的恶性肿瘤之一。本文旨在综述以下两方面的数据:(1)肿瘤早期检测的流行病学及筛查项目;(2)诊断成像及治疗方面的进展。

方法

对1985年1月至1997年12月间发表的相关英文文章进行综述。通过使用关键词“肝细胞癌”在医学文献数据库(Medline)中检索文章。对这些文章参考文献中引用的文章进行手工检索。

结果

肝细胞癌的地理分布不均一。尽管其危险因素已被确定,但筛查项目的效果仍不确定。随着双期螺旋计算机断层扫描和使用特定造影剂的磁共振成像技术的近期应用,成像技术有了显著改进。由于缺乏严格对照试验,保守治疗和手术切除的相对疗效尚不确定。

结论

肝细胞癌通常是两种疾病的问题,即恶性肿瘤本身和肝硬化。这使得即使在技术上能够成功进行手术切除时,治疗也很少能治愈。肝移植可能是一种确定性治疗方法,但受限于供体资源。

相似文献

1
Hepatocellular carcinoma.肝细胞癌
Br J Surg. 1998 Oct;85(10):1319-31. doi: 10.1046/j.1365-2168.1998.00865.x.
2
Hepatocellular carcinoma.肝细胞癌
Curr Opin Gastroenterol. 2006 May;22(3):248-53. doi: 10.1097/01.mog.0000218961.86182.8c.
3
Hepatocellular carcinoma: current management and recent advances.肝细胞癌:当前的治疗与最新进展
Hepatobiliary Pancreat Dis Int. 2008 Jun;7(3):237-57.
4
Epidemiology and outcome of hepatocellular carcinoma in Lombardy.伦巴第地区肝细胞癌的流行病学与转归
Dig Liver Dis. 2007 Nov;39(11):1011-7. doi: 10.1016/j.dld.2007.06.018. Epub 2007 Oct 23.
5
Hepatocellular carcinoma: overcoming challenges in disease management.肝细胞癌:克服疾病管理中的挑战
Clin Gastroenterol Hepatol. 2006 Mar;4(3):252-61. doi: 10.1016/j.cgh.2006.01.001.
6
Multidisciplinary treatment of patients with hepatocellular carcinoma.肝细胞癌患者的多学科治疗
Expert Rev Anticancer Ther. 2006 Oct;6(10):1377-84. doi: 10.1586/14737140.6.10.1377.
7
Epidemiology, screening, diagnosis and treatment of hepatocellular carcinoma.肝细胞癌的流行病学、筛查、诊断与治疗
Minerva Gastroenterol Dietol. 2009 Jun;55(2):123-38.
8
Interferon therapy does not prevent hepatocellular carcinoma in HCV compensated cirrhosis.干扰素治疗不能预防丙型肝炎病毒代偿性肝硬化患者发生肝细胞癌。
Hepatogastroenterology. 2002 Nov-Dec;49(48):1636-8.
9
[Hepatocellular carcinoma--epidemiology and treatment].[肝细胞癌——流行病学与治疗]
Przegl Epidemiol. 2006;60(4):731-40.
10
Hemoperitoneum in patients with ascites.腹水患者的腹腔积血
Am J Gastroenterol. 1997 Apr;92(4):567-75.

引用本文的文献

1
Evodiamine Induces Apoptosis in SMMC-7721 and HepG2 Cells by Suppressing NOD1 Signal Pathway.吴茱萸碱通过抑制 NOD1 信号通路诱导 SMMC-7721 和 HepG2 细胞凋亡。
Int J Mol Sci. 2018 Oct 31;19(11):3419. doi: 10.3390/ijms19113419.
2
The Geography of Primary Hepatic Neoplasms Treatments in Canada: Changes in Latitudes and Changes in Attitudes.加拿大原发性肝脏肿瘤治疗的地域分布:观念在转变,地域在变迁。
Can J Gastroenterol Hepatol. 2017;2017:9365657. doi: 10.1155/2017/9365657. Epub 2017 Jul 26.
3
Role of curative treatment in patients with intermediate-stage hepatocellular carcinoma.
根治性治疗在中期肝细胞癌患者中的作用
Jpn J Radiol. 2017 May;35(5):254-261. doi: 10.1007/s11604-017-0628-9. Epub 2017 Mar 29.
4
E/ERβ Inhibits PPARα to Regulate Cell-Proliferation and Enhance Apoptosis in Hep3B-Hepatocellular Carcinoma.E/ERβ抑制PPARα以调节Hep3B肝癌细胞的增殖并增强其凋亡。
Pathol Oncol Res. 2017 Jul;23(3):477-485. doi: 10.1007/s12253-016-0136-8. Epub 2016 Oct 18.
5
Zebrafish as a disease model for studying human hepatocellular carcinoma.斑马鱼作为研究人类肝细胞癌的疾病模型。
World J Gastroenterol. 2015 Nov 14;21(42):12042-58. doi: 10.3748/wjg.v21.i42.12042.
6
Gut-liver axis improves with meloxicam treatment after cirrhotic liver resection.肝硬化肝切除术后使用美洛昔康治疗可改善肠-肝轴。
World J Gastroenterol. 2014 Oct 28;20(40):14841-54. doi: 10.3748/wjg.v20.i40.14841.
7
Frequency of elevated biomarkers in patients with cryptogenic hepatocellular carcinoma.不明原因的肝细胞癌患者中生物标志物升高的频率。
Med Sci Monit. 2013 Sep 6;19:742-50. doi: 10.12659/MSM.889361.
8
Current understanding on antihepatocarcinoma effects of xiao chai hu tang and its constituents.小柴胡汤及其成分抗肝癌作用的研究进展。
Evid Based Complement Alternat Med. 2013;2013:529458. doi: 10.1155/2013/529458. Epub 2013 Jun 18.
9
First in-human intraoperative imaging of HCC using the fluorescence goggle system and transarterial delivery of near-infrared fluorescent imaging agent: a pilot study.使用荧光镜系统和经动脉递送近红外荧光成像剂进行 HCC 的首次人体术中成像:一项初步研究。
Transl Res. 2013 Nov;162(5):324-331. doi: 10.1016/j.trsl.2013.05.002. Epub 2013 Jun 5.
10
Intraoperative detection of liver tumors aided by a fluorescence goggle system and multimodal imaging.荧光眼镜系统和多模态成像辅助下的肝肿瘤术中检测。
Analyst. 2013 Apr 21;138(8):2254-7. doi: 10.1039/c3an00165b.